Incyte Corp (INCY)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$118.54
Buy
$118.75
$-0.455 (-0.38%)
Prices updated at 18 Nov 2026, 16:50 EST
| Prices minimum 15 mins delay
Prices in USD
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumat ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
| $120.99 - $118.40 | |
| $132.60 - $89.25 | |
| - | |
| 24,274.41m | |
| 60.76 | |
| - | |
| 230,596 | |
| 4.30 | |
| 1,798,023.85 | |
| 0.70 | |
| 198.46m | |
| US45337C1027 | |
| 6.41 | |
| - |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.